Pharmiweb ChannelsAll | PharmaCo | Clinical Research | R&D/BioTech | Sales/Mktg | Healthcare | Recruitment | Pharmacy | Medical Comms

Pharmiweb.com RSS Feed Pharmiweb.com RSS Feeds

Advertising

Press Release

"Bachelor in Paradise" Couple Jade Roper and Tanner Tolbert Announce Arrival of First "Ava Baby" to "Bachelor Nation"

Ava
Posted on: 19 Aug 17

SAN FRANCISCO, Aug. 18, 2017 /PRNewswire/ -- Ava, a medical technology company focused on innovations in women's reproductive health, today announced the arrival of its first "celebrity baby" conceived with the help of its Ava fertility tracking sensor bracelet launched last summer – "Bachelor in Paradise" couple Jade Roper and Tanner Tolbert's new baby girl born Thursday, August 17 at 10:03 am.

E! broke the story that Roper, 30, and Tolbert, 30, welcomed their first child and shortly afterward thanked Ava for helping them start their family. Jade started wearing the Ava bracelet in October, first posted about using Ava in November, and became pregnant in December. Tanner Tolbert says, "I'm so glad Jade started using the Ava bracelet to help make our dream of being parents a reality. Once she started wearing Ava to bed to track her cycle, we got pregnant in two months."

Jade, who continued to use Ava throughout her pregnancy to monitor her changing body, said, "It took all of the stress out of it for us and I really love the product!"

Since its consumer launch in August 2016, the Ava fertility tracking bracelet has already helped more than 500 women conceive. According to Lea von Bidder, Ava users from across the US and Europe are reporting about 5-10 pregnancies a day. 

How Ava Works

Ava is a sensor bracelet that uses new technology to precisely detect the fertile days during a woman's monthly cycle in real time. Worn only at night while sleeping, Ava measures nine physiological parameters including pulse rate, breathing rate, heart rate variability, temperature that, in combination, help indicate a rise in reproductive hormones estradiol and progesterone. The impact of the rise of these hormones on the physiological parameters is used to detect a 5.3-day fertile window in a woman's cycle. Because users simply wear the Ava bracelet at night and sync it with the Ava app in the morning, they avoid the hassles, mess and invasiveness of other fertility tracking methods like ovulation strips and BBT thermometers. An FDA Class 1 medical device, the Ava bracelet was proven in a recently concluded clinical study at the University Hospital of Zurich to detect an average of 5.3 fertile days per cycle - in real time - with 89 percent accuracy.

Media Contact:
Aimee Grove
M: (415) 706-1906
172780@email4pr.com

Editor's Details

Mike Wood
PharmiWeb.com
www.pharmiweb.com
editor@pharmiweb.com

Last updated on: 19/08/2017

Advertising
Site Map | Privacy & Security | Cookies | Terms and Conditions

PharmiWeb.com is Europe's leading industry-sponsored portal for the Pharmaceutical sector, providing the latest jobs, news, features and events listings.
The information provided on PharmiWeb.com is designed to support, not replace, the relationship that exists between a patient/site visitor and his/her physician.